AMH reflects how many eggs remain, not their quality, and it cannot tell you whether you will conceive. It is one input among several, and it is always interpreted together with your age and other tests.
Few blood tests provoke as much anxiety as AMH. A number arrives, often without much explanation attached, and within minutes it can feel like a verdict on whether you will ever have children. Women describe searching for the figure online at two in the morning and finding charts that seem to sort them into categories they never agreed to be sorted into. That reaction is entirely understandable, and it is also, in most cases, a misreading of what the test is for.
AMH is a useful measurement. It is not a fertility score, it is not a prediction, and on its own it cannot tell you whether you will conceive. This guide explains what the hormone is, what the test genuinely measures and what it cannot see, how results are interpreted in the context of your age, what low and high readings actually indicate, what can distort a result, and how the number is used in practice when planning treatment. It also addresses the emotional side, because that is a real part of receiving this test.
What Is AMH and Where Does It Come From?
AMH stands for anti-Mullerian hormone. In the ovary, it is produced by the granulosa cells that surround small developing follicles, specifically the preantral and small antral follicles that are in the early stages of maturing. Every follicle contains an immature egg, and every month a group of these small follicles begins to grow, with normally one going on to release an egg.
Because AMH is made by this pool of small follicles, the amount circulating in your blood reflects roughly how many of them you have at that moment. A larger pool produces more AMH, a smaller pool produces less. This relationship is what makes the hormone useful as an indirect marker of the ovarian follicle pool, often called ovarian reserve.
AMH has a second role earlier in life. In a developing male foetus it causes the structures that would otherwise become the uterus and fallopian tubes to regress, which is where its slightly unusual name comes from. In women it rises through adolescence, peaks somewhere in the mid twenties, and then declines gradually with age until it becomes very low around the menopause. That age related decline is normal and expected, and it is the backdrop against which any individual result has to be read.
What the Test Measures: Quantity, Not Quality
This distinction is the single most important thing to understand about AMH, and it is the one most often lost. AMH gives an estimate of how many eggs remain in the pool. It says nothing whatsoever about the quality of those eggs, meaning their chromosomal normality and their capacity to fertilise and develop into a healthy embryo.
Egg quality is determined overwhelmingly by age. A woman of thirty with a low AMH has fewer eggs than average for her age, but those eggs are still thirty year old eggs, with the chromosomal profile that implies. A woman of forty two with a reassuringly high AMH has plenty of eggs, but they are forty two year old eggs. The number tells you about the size of the basket, not what is inside each one.
This is why AMH cannot predict whether you will conceive naturally. Conception requires one good egg in a given month, not a large stock of them. Many women with low AMH conceive without difficulty, and some women with high AMH struggle for reasons entirely unconnected to their egg supply, such as tubal damage, endometriosis or a male factor. Reading AMH as a fertility score confuses two quite separate things.
How and When Is the AMH Test Done?
Practically, this is one of the simplest tests in gynaecology. It requires a single blood sample from a vein in the arm, with no fasting and no preparation. Results usually come back within a few days.
One of its main advantages is timing flexibility. Unlike FSH and oestradiol, which must be measured in the first few days of the cycle to be meaningful, AMH remains relatively stable across the menstrual cycle. It can therefore be taken on any day, which is genuinely helpful for women with irregular periods where identifying day three is difficult or impossible. It can also be measured in women who are not menstruating at all for other reasons.
There is one technical caveat worth knowing. Different laboratories have used different assays and different units over the years, with results reported in nanograms per millilitre or picomoles per litre. This means a result from one laboratory cannot always be compared directly with one from another, and the reference ranges printed on the report belong to that laboratory. If you are comparing an old result with a new one, check that both came from the same laboratory and the same units, or ask for them to be converted. Small fluctuations between tests are common and rarely significant on their own.
How Results Are Interpreted and Why Age Sets the Context
Laboratories generally group results into broad bands: low, within the expected range, and high. Those bands are useful as a starting point but they are blunt, because what counts as low depends heavily on how old you are. A result that would be unremarkable at forty may be worth investigating at twenty eight, and the same figure carries different implications in each case.
AMH declines with age in every woman, so the clinically meaningful question is not simply whether your value is low but whether it is low for your age. A reading that sits below the expected range for a woman in her twenties suggests the follicle pool is diminishing earlier than usual, which is worth understanding and may influence timing decisions. The identical number in a woman approaching her mid forties is simply what the ovary does at that stage.
Age also outweighs AMH when it comes to the outcomes people actually care about. Because egg quality tracks age so closely, a woman's age remains the strongest single predictor of her chance of a healthy pregnancy, whether naturally or with treatment. AMH refines the picture and helps with planning, but it does not override age, and no doctor should interpret it as though it does. This is why a result should always be discussed in a consultation rather than read off a report at home.
What a Low AMH Does and Does Not Mean
A low AMH means one thing: your ovaries currently hold a smaller pool of small follicles than expected. That is the entire content of the finding. Everything else that people commonly attach to it is inference, and much of that inference is wrong.
A low AMH is not a diagnosis of infertility. It does not mean you cannot conceive naturally, and studies of women trying to conceive without treatment have found that AMH is a poor predictor of whether they will succeed in a given timeframe. It does not mean your eggs are of poor quality. It does not mean menopause is imminent, although a very low result in a young woman does warrant assessment for primary ovarian insufficiency alongside other tests.
What a low result does suggest is that the ovaries are likely to produce fewer eggs in response to stimulation, which matters if IVF is being planned, and that the window for building a larger stock of eggs, for example through freezing, may be narrower than average. It is therefore a planning signal rather than a prognosis.
It is also worth saying plainly that a single low result should prompt a conversation, not a decision. Repeating the test, adding an antral follicle count and reviewing the whole clinical picture will tell you far more than one figure ever can. If it has been a while, a full fertility assessment is a more useful next step than another isolated blood test.
What a High AMH Can Indicate, Including PCOS
A result above the expected range is not automatically good news, and it is not automatically bad news either. In some women it simply reflects a naturally generous follicle pool, particularly at a younger age, and carries no implications at all.
More often, a markedly raised AMH points towards polycystic ovary syndrome. In PCOS the ovaries contain an unusually large number of small antral follicles that begin to develop but stall before maturing, and since each of those follicles produces AMH, the total in the bloodstream rises. This is a direct reflection of the underlying follicle pattern rather than a coincidence, and AMH levels in PCOS often sit well above the typical range.
A high result does not by itself make the diagnosis, which still rests on the combination of irregular or absent ovulation, clinical or biochemical signs of raised androgens, and ultrasound appearance. But a strikingly high AMH in a woman with irregular cycles is a useful pointer towards further assessment.
There is a practical consequence too. Women with high AMH tend to respond strongly to ovarian stimulation, which raises the risk of ovarian hyperstimulation syndrome during IVF. Knowing the level in advance allows the starting dose to be lowered and the cycle monitored more carefully, so a high result actively improves safety rather than causing a problem.
Factors That Can Affect Your AMH Result
AMH is more stable than most reproductive hormones, but it is not immovable, and several things can shift a reading in ways that have nothing to do with your underlying reserve.
Hormonal contraception is the most common. Combined pills, and to a lesser extent other hormonal methods, suppress the small follicles that produce AMH, and long term use can lower a measured result meaningfully. The effect is reversible, and levels typically recover within a few months of stopping. If your result was taken while you were on the pill and it came back low, that context matters and the test may be worth repeating later.
Ovarian surgery is another important factor. Removing a cyst, particularly an endometrioma, inevitably takes some healthy ovarian tissue with it and can reduce AMH afterwards. Chemotherapy and pelvic radiotherapy have a much larger and often permanent effect, which is why fertility preservation is discussed before cancer treatment where possible.
Smoking is associated with lower levels and earlier ovarian ageing. Vitamin D deficiency and significant obesity have both been linked to modest reductions, though the evidence is less consistent. Genetics play a substantial part, and a family history of early menopause is relevant information. Notably, there is no diet, supplement or lifestyle change that reliably raises AMH, and products marketed on that promise are not supported by good evidence.
AMH and IVF Planning
This is where AMH is genuinely at its most useful, and it is the context in which it was largely developed. When planning a stimulation cycle, the doctor needs to predict how the ovaries will respond to a given dose of medication, and AMH is among the more reliable markers available for that purpose.
A woman with low AMH is likely to produce fewer follicles, so a higher starting dose or a different protocol may be chosen, and expectations about the number of eggs collected can be set honestly from the start. A woman with high AMH is likely to respond vigorously, so a lower dose and a protocol designed to reduce hyperstimulation risk will usually be preferred. In both cases the aim is the same: a safe cycle with a sensible yield.
AMH also informs the wider conversation. It helps in deciding whether to consider more than one egg collection, in discussing egg or embryo freezing, and in setting realistic expectations before a cycle rather than after it. What it does not do is determine whether treatment is offered. A low AMH is not a barrier to IVF treatment, and decisions about proceeding rest on the whole clinical picture, above all on age. It predicts the response to stimulation, which is a different question from whether a pregnancy will follow.
Why AMH Should Never Be Interpreted Alone
No competent assessment of ovarian reserve relies on a single marker, and AMH is no exception. It is one instrument in a small orchestra, and the sound only makes sense when the others are playing.
The antral follicle count is the natural companion test. Performed by transvaginal ultrasound, usually in the early part of the cycle, it counts the small follicles visible in each ovary. Because it looks at the same population of follicles that produce AMH, the two tests tend to agree, and when they disagree that discrepancy is itself informative and prompts a closer look.
FSH and oestradiol, measured together on day two or three of the cycle, add another perspective. A rising FSH indicates that the brain is working harder to recruit follicles, which suggests a diminishing reserve. Oestradiol must be measured alongside it, because a raised oestradiol can artificially suppress FSH and produce a falsely reassuring result. Thyroid function and prolactin are often checked as well, since both influence ovulation and cycle regularity.
Above all, age remains the anchor. A doctor reading these results together, alongside your cycle history, medical background and any symptoms, will reach a far more accurate impression than any single value permits. This is precisely why an AMH result posted online for strangers to interpret is close to meaningless.
Receiving a Low Number: How to Think About It
The emotional impact of a low AMH result is often disproportionate to its clinical meaning, and that is not the patient's fault. A number feels definitive in a way that words do not. It can seem like a countdown has been started, and many women describe an immediate sense of loss for pregnancies they had not yet planned.
It helps to hold on to a few facts. The result describes the current size of a pool, not your capacity to conceive. It cannot tell you when your menopause will be. It does not describe the quality of your eggs. Women with low AMH conceive naturally every day, and the test was never designed to predict that outcome. If it were a reliable predictor of natural conception, it would be used for that purpose, and it is not.
What a low result can reasonably do is inform your timing. It may prompt you to have a fuller assessment sooner, to talk to a partner earlier than you had planned, or to consider egg freezing if you are not ready to try now. Those are constructive responses to information.
If the result has left you feeling distressed, say so at your appointment. That reaction is common and clinicians are used to it, and having the number explained properly in context resolves a great deal of the fear. Fertility counselling is available in most services and is a reasonable thing to accept.
When to Get Tested and When to See a Specialist
AMH is not a screening test for the general population, and testing without a reason often creates worry rather than clarity. It is most useful when there is a specific question to answer.
Reasonable reasons to test include: you are planning fertility treatment and the response to stimulation needs predicting; you are considering egg freezing and want to plan the timing; you have had ovarian surgery or are facing treatment that may damage the ovaries; you have a family history of early menopause; or your periods have become irregular or stopped and the cause is being investigated.
Arrange a consultation with a gynaecologist or fertility specialist if you have been trying to conceive for twelve months without success, or for six months if you are over thirty five. See a doctor sooner if your periods have stopped for several months outside pregnancy, if you have menopausal symptoms such as hot flushes before the age of forty, if you have had ovarian surgery and want to understand its effect, or if you have already had an AMH result and nobody has explained it to you properly.
Do not act on an unexplained number alone. Bring the report, ask which laboratory and units were used, ask what the result means for your age specifically, and ask what the recommended next step would be. A single figure deserves a conversation, not a decision.
References
This article was prepared with reference to the following independent health sources.
- NHS. Infertility
- World Health Organization. Infertility
